Condition

Bendamustine (2)

Aggressive Non Hodgkin's Lymphoma (1)

Autologous Stem Cell Transplant (1)

Conditioning Therapy (1)

Multiple Myeloma (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Grupo Espanol de Linfomas y Transplante Autologo de Medula Osea (1)

Liao Aijun (1)

Collaborator

Intervention

bendamustine (1)

bendamustine-eam (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

bendamustine

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)

Recruiting

Bendamustine
Multiple Myeloma

Bendamustine

Shenyang, Liaoning, China

Shengjing Hospital of China Medical University

Aug 7, 2021

Bendamustine, Conditioning Therapy, Autologous Stem Cell Transplant Trial in Spain (Bendamustine-EAM)

Completed

Bendamustine
+3 more

Bendamustine-EAM

Santiago, A Coruña, Spain
+20 more

Feb 15, 2016